Stockreport

Praxis Precision Medicines to Present at Upcoming Investor Conferences

Praxis Precision Medicines, Inc.  (PRAX) 
PDF BOSTON, May 11, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into [Read more]